140 related articles for article (PubMed ID: 30844662)
1. Novel potential biomarkers for pancreatic cancer - A systematic review.
Litman-Zawadzka A; Łukaszewicz-Zając M; Mroczko B
Adv Med Sci; 2019 Sep; 64(2):252-257. PubMed ID: 30844662
[TBL] [Abstract][Full Text] [Related]
2. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
[TBL] [Abstract][Full Text] [Related]
3. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 expression in activated pancreatic satellite cells promotes fibrosis in chronic pancreatitis/pancreatic cancer via the TGF-β1/Smad pathway.
Tang D; Wu Q; Zhang J; Zhang H; Yuan Z; Xu J; Chong Y; Huang Y; Xiong Q; Wang S; Tian Y; Lu Y; Ge X; Shen W; Wang D
Oncol Rep; 2018 Mar; 39(3):1347-1355. PubMed ID: 29328490
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
6. [The role of metalloproteinases and their inhibitors in pancreatic cancer].
Łukaszewicz M; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2008 Apr; 62():141-7. PubMed ID: 18414340
[TBL] [Abstract][Full Text] [Related]
7. The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer.
Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240178
[TBL] [Abstract][Full Text] [Related]
8. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
[TBL] [Abstract][Full Text] [Related]
9. LncRNAs in pancreatic cancer.
Huang X; Zhi X; Gao Y; Ta N; Jiang H; Zheng J
Oncotarget; 2016 Aug; 7(35):57379-57390. PubMed ID: 27429196
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer.
Song H; Dong M; Zhou J; Sheng W; Li X; Gao W
Oncol Rep; 2018 Mar; 39(3):1432-1440. PubMed ID: 29344675
[TBL] [Abstract][Full Text] [Related]
12. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
[TBL] [Abstract][Full Text] [Related]
13. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.
Gzil A; Zarębska I; Bursiewicz W; Antosik P; Grzanka D; Szylberg Ł
Mol Biol Rep; 2019 Dec; 46(6):6629-6645. PubMed ID: 31486978
[TBL] [Abstract][Full Text] [Related]
14. Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.
Sheng W; Dong M; Chen C; Li Y; Liu Q; Dong Q
Oncotarget; 2017 Feb; 8(9):14359-14373. PubMed ID: 27092875
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
16. Cellular Senescence, Represented by Expression of Caveolin-1, in Cancer-Associated Fibroblasts Promotes Tumor Invasion in Pancreatic Cancer.
Yamao T; Yamashita YI; Yamamura K; Nakao Y; Tsukamoto M; Nakagawa S; Okabe H; Hayashi H; Imai K; Baba H
Ann Surg Oncol; 2019 May; 26(5):1552-1559. PubMed ID: 30805811
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6: a villain in the drama of pancreatic cancer development and progression.
Holmer R; Goumas FA; Waetzig GH; Rose-John S; Kalthoff H
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):371-80. PubMed ID: 25100121
[TBL] [Abstract][Full Text] [Related]
18. LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients.
Zhang J; Zhang L; Li C; Yang C; Li L; Song S; Wu H; Liu F; Wang L; Gu J
Cell Oncol (Dordr); 2018 Feb; 41(1):73-84. PubMed ID: 29168159
[TBL] [Abstract][Full Text] [Related]
19. A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer.
Wu X; Zhang ZX; Chen XY; Xu YL; Yin N; Yang J; Zhu DM; Li DC; Zhou J
Proteomics Clin Appl; 2019 Sep; 13(5):e1800195. PubMed ID: 31025496
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin promotes EMT in pancreatic cancer via mediating Ca
Sheng W; Wang G; Tang J; Shi X; Cao R; Sun J; Lin YH; Jia C; Chen C; Zhou J; Dong M
J Exp Clin Cancer Res; 2020 Oct; 39(1):209. PubMed ID: 33028359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
